DCAS9P

Dead Cas9 plasmid

Manufacturer: Sigma Aldrich

Select a Size

Pack Size SKU Availability Price
1 μG DCAS9P-1-μG In Stock ₹ 26,975.90

DCAS9P - 1 μG

₹ 26,975.90

In Stock

Quantity

1

Base Price: ₹ 26,975.90

GST (18%): ₹ 4,855.662

Total Price: ₹ 31,831.562

recombinant

expressed in E. coli

form

liquid

packaging

vial of 50 μL

concentration

20 ng/μL in TE buffer; DNA (1μg of plasmid DNA)

application(s)

CRISPR

Promoter

Promoter name: CMV

selection

kanamycin

shipped in

dry ice

storage temp.

−20°C

Related Products

Img

Sigma Aldrich

FNCAS9P

--

Img

Sigma Aldrich

CAS9D10AP

--

Img

Sigma Aldrich

CAS9D10AGFPP

--

Img

Sigma Aldrich

CAS9P

--

Img

Sigma Aldrich

CAS9D10ARFPP

--

Img

Sigma Aldrich

CAS9GFPP

--

Img

Sigma Aldrich

CAS9GEMP

--

Img

Sigma Aldrich

CRISPRPL01

--

Description

  • General description: This product is an expression plasmid that utilizes the CMV promoter for strong transient expression of Dead Cas9 (CMV-dCas9). The dCas9 expression plasmid is one part of a two part CRISPR system with individual dCas9 and gRNA expression vectors.To order gRNA in any format click here
  • Application: Functional Genomics/Target ValidationProxy CRISPRSuitable for genomic DNA detection
  • Features and Benefits: Highly specificSequence verifiedReady to use purified plasmid DNA
  • Principle: CRISPR/Cas systems are employed by bacteria and archaea as a defense against invading viruses and plasmids. Recently, the type II CRISPR/Cas system from the bacterium Streptococcus pyogenes has been engineered to function in eukaryotic systems using two molecular components: a single Cas9 protein and a non-coding guide RNA (gRNA).The Cas9 endonuclease can be rendered inactive (dCas9) with mutations to the two protein domains, RuvC and HnH (D10A and H840A respectively), which are responsible for nuclease activity. The nuclease deficient protein can then be programmed with a gRNA and directed to bind at a desired sequence of DNA. Variants of programmable endonucleases are often unable to cleave a large number of the targets that are efficiently cleaved by canonical SpCas9 in human cells. Cotargeting dead Cas9 may alter local chromatin structures and render otherwise inaccessible target sites now accessible and cleavable by alternative nucleases such as type II-B FnCas9, type II-C CjCas9 and NcCas9 and type V FnCpf1.[1]
  • Legal Information: CRISPR Label License

SAFETY INFORMATION

WGK

WGK 2

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Compare Similar Items

Show Difference

Img

Sigma Aldrich

DCAS9P

--


recombinant:
expressed in E. coli

form:
liquid

packaging:
vial of 50 μL

concentration:
20 ng/μL in TE buffer; DNA (1μg of plasmid DNA)

application(s):
CRISPR

Promoter:
Promoter name: CMV

selection:
kanamycin

shipped in:
dry ice

storage temp.:
−20°C

Img

Sigma Aldrich

DCAS9P300

--


recombinant:
expressed in E. coli

form:
__

packaging:
vial of 50 μL

concentration:
20 ng/μL in TE buffer; DNA (1μg of plasmid DNA)

application(s):
CRISPR

Promoter:
__

selection:
__

shipped in:
dry ice

storage temp.:
−20°C

Img

Sigma Aldrich

DCAS9P300RFP

--


recombinant:
expressed in E. coli

form:
liquid

packaging:
vial of 50 μL

concentration:
20 ng/μL in TE buffer; DNA (1μg of plasmid DNA)

application(s):
CRISPR

Promoter:
__

selection:
__

shipped in:
dry ice

storage temp.:
−20°C

Img

Sigma Aldrich

DCAS9P300VP

--


recombinant:
expressed in E. coli

form:
liquid

packaging:
vial of 50 μL

concentration:
20 ng/μL in TE buffer; DNA (1μg of plasmid DNA)

application(s):
CRISPR

Promoter:
__

selection:
__

shipped in:
dry ice

storage temp.:
−20°C